Section Arrow
SLNO.NASDAQ
- Soleno Therapeutics
Quotes are at least 15-min delayed:2025/09/05 18:00 EDT
After Hours
Last
 69.77
0 (0.00%)
Bid
69.71
Ask
69.77
High 69.77 
Low 69.77 
Volume 80068 
Regular Hours
Last
 69.77
+0.2 (+0.29%)
Day High 
70.06 
Prev. Close
69.57 
1-M High
87.17 
Volume 
631.40K 
Bid
69.71
Ask
69.77
Day Low
67.51 
Open
69.82 
1-M Low
63.46 
Market Cap 
3.70B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 68.2 
20-SMA 72.31 
50-SMA 79.89 
52-W High 90.3199 
52-W Low 41.5 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.22/3.11
Enterprise Value
3.75B
Balance Sheet
Book Value Per Share
4.52
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
GNPXGenprex0.2295+0.0738+47.40%0.18PE
After Hours 0.209 -0.0205 -8.93%
ADAPAdaptimmune Therapeutics plc0.041-0.01-19.61%-- 
After Hours 0.0427 +0.0017 +4.15%
NUVBNuvation Bio3.9+0.48+14.04%-- 
After Hours 3.92 +0.02 +0.51%
KLTOKlotho Neurosciences Inc0.4851-0.0099-2.00%-- 
After Hours 0.4738 -0.0113 -2.33%
IOVAIovance Biotherapeutics2.49+0.29+13.18%-- 
After Hours 2.49 0 0.00%
Quotes are at least 15-min delayed:2025/09/05 18:00 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.